Our results suggest that HK Δsgl1 represents a clinically relevant, efficacious vaccine that confers robust host protection in three models of vaccination against cryptococcosis even during CD4-deficiency. The gene discussed is CD4; the disease is hyperinsulinemic hypoglycemia, familial, 4.